SEC Comment Letter for HELIUS MEDICAL TECHNOLOGIES, INC. (HSDT, HSDTW) (CIK 0001610853) (HSDT) — Feb 3, 2020
HELIUS MEDICAL TECHNOLOGIES, INC. (HSDT, HSDTW) (CIK 0001610853)
Date: Feb. 3, 2020 · CIK: 0001610853 · Accession: 0000000000-20-001024
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-236101
Letter
February 3, 2020 Philippe Deschamps President and Chief Executive Officer Helius Medical Technologies, Inc. 642 Newtown Yardley Road, Suite 100 Newtown, Pennsylvania 18940 Re:Helius Medical Technologies, Inc. Registration Statement on Form S-3 Filed January 27, 2020 File No. 333-236101 Dear Mr. Deschamps: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Chris Edwards at (202) 551-6761 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc: Darren DeStefano
Show Raw Text
February 3, 2020
Philippe Deschamps
President and Chief Executive Officer
Helius Medical Technologies, Inc.
642 Newtown Yardley Road, Suite 100
Newtown, Pennsylvania 18940
Re:Helius Medical Technologies, Inc.
Registration Statement on Form S-3
Filed January 27, 2020
File No. 333-236101
Dear Mr. Deschamps:
This is to advise you that we have not reviewed and will not review your registration
statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you
that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Chris Edwards at (202) 551-6761 with any questions.
Sincerely,
Division of Corporation Finance
Office of Life Sciences
cc: Darren DeStefano